Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials

Bozcuk H., Artac M., Ozdogan M., Savas B.

CANCER, cilt.104, sa.12, ss.2650-2657, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 104 Sayı: 12
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1002/cncr.21540
  • Dergi Adı: CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2650-2657
  • Anahtar Kelimeler: small cell lung cancer (SCLC), maintenance/consolidation chemotherapy, metaanalysis, COOPERATIVE-ONCOLOGY-GROUP, CISPLATIN PLUS ETOPOSIDE, MAINTENANCE CHEMOTHERAPY, COMBINATION CHEMOTHERAPY, ALTERNATING CHEMOTHERAPY, INDUCTION CHEMOTHERAPY, PROGNOSTIC-FACTORS, RADIATION-THERAPY, IMPROVE SURVIVAL, CLINICAL-TRIAL
  • Akdeniz Üniversitesi Adresli: Hayır

Özet

BACKGROUND. The role of maintenance/consolidation chemotherapy was assessed in the management of small cell lung cancer (SCLC) via a metaanalytic approach.